| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | — |
| Cost of Revenue | $505K | — |
| R&D Expense | $3.8M | -39.1% |
| SG&A Expense | $13.1M | -3.3% |
| Operating Income | -$16.2M | +12.3% |
| Income Tax | $0 | — |
| Net Income | -$28.6M | -13.9% |
| EPS (Basic) | -$1.34 | +43.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.8M | +440.3% |
| Accounts Receivable | $161K | — |
| Current Assets | $8.9M | +169.3% |
| Total Assets | $13.0M | +254.9% |
| Current Liabilities | $28.6M | +30.7% |
| Total Liabilities | $28.9M | +7.5% |
| Stockholders' Equity | -$15.9M | +31.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.1M | -32.7% |
| Investing Cash Flow | -$2.8M | — |
| Financing Cash Flow | $23.3M | +211.0% |